Population-based CD4 Counts in a Rural Area in South Africa with High HIV Prevalence and High Antiretroviral Treatment Coverage
Overview
Affiliations
Background: Little is known about the variability of CD4 counts in the general population of sub-Saharan Africa countries affected by the HIV epidemic. We investigated factors associated with CD4 counts in a rural area in South Africa with high HIV prevalence and high antiretroviral treatment (ART) coverage.
Methods: CD4 counts, health status, body mass index (BMI), demographic characteristics and HIV status were assessed in 4990 adult resident participants of a demographic surveillance in rural KwaZulu-Natal in South Africa; antiretroviral treatment duration was obtained from a linked clinical database. Multivariable regression analysis, overall and stratified by HIV status, was performed with CD4 count levels as outcome.
Results: Median CD4 counts were significantly higher in women than in men overall (714 vs. 630 cells/µl, p<0.0001), both in HIV-uninfected (833 vs. 683 cells/µl, p<0.0001) and HIV-infected adults (384.5 vs. 333 cells/µl, p<0.0001). In multivariable regression analysis, women had 19.4% (95% confidence interval (CI) 16.1-22.9) higher CD4 counts than men, controlling for age, HIV status, urban/rural residence, household wealth, education, BMI, self-reported tuberculosis, high blood pressure, other chronic illnesses and sample processing delay. At ART initiation, HIV-infected adults had 21.7% (95% CI 14.6-28.2) lower CD4 counts than treatment-naive individuals; CD4 counts were estimated to increase by 9.2% (95% CI 6.2-12.4) per year of treatment.
Conclusions: CD4 counts are primarily determined by sex in HIV-uninfected adults, and by sex, age and duration of antiretroviral treatment in HIV-infected adults. Lower CD4 counts at ART initiation in men could be a consequence of lower CD4 cell counts before HIV acquisition.
Estimating the burden of mpox among MSM in South Africa.
McCabe R, Johnson L, Whittles L BMJ Glob Health. 2025; 10(2).
PMID: 39971582 PMC: 11840921. DOI: 10.1136/bmjgh-2024-017268.
Hypertension in people living with HIV on combined antiretroviral therapy in rural Tanzania.
Trifiro S, Cavallin F, Mangi S, Mhaluka L, Maffoni S, Taddei S Afr Health Sci. 2023; 23(1):129-136.
PMID: 37545920 PMC: 10398461. DOI: 10.4314/ahs.v23i1.15.
Birhanu S, Winterhalter F, Stupp P, Cates M, Rottinghaus E, Yavo D Microbiol Spectr. 2023; 11(3):e0314822.
PMID: 37071009 PMC: 10269725. DOI: 10.1128/spectrum.03148-22.
Molecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019.
Serwin K, Urbanska A, Scheibe K, Witak-Jedra M, Jankowska M, Hlebowicz M Sci Rep. 2021; 11(1):16609.
PMID: 34400726 PMC: 8367969. DOI: 10.1038/s41598-021-96125-w.
Wang D, Ma S, Ma Y, Guo H, Li P, Yang C Evid Based Complement Alternat Med. 2021; 2021:5576612.
PMID: 34326884 PMC: 8302365. DOI: 10.1155/2021/5576612.